NEWS
2023-06-01
LKtime Biotech Enters Strategic Cooperation with Shanghai Bio-Pharmaceutical Technology Development Center and Adds a 2000L Production Line
2024-12-19
Lktime Biotech Obtains Pathogenic Microorganism Laboratory Registration Certificate (BSL-2)
2024-07-02
LKtime raises 190 million yuan in Series B funding, setting a new benchmark for biologics CDMO in China
2023-03-21
Strategic Cooperation | Shanghai LKtime Biotech and Dartsbio (Guangdong) Officially Sign Strategic Cooperation Agreement
2024-12-19
Lktime Biotech Obtains Pathogenic Microorganism Laboratory Registration Certificate (BSL-2)
Learn More
2024-07-02
LKtime raises 190 million yuan in Series B funding, setting a new benchmark for biologics CDMO in China
Learn More
2023-06-01
LKtime Biotech Enters Strategic Cooperation with Shanghai Bio-Pharmaceutical Technology Development Center and Adds a 2000L Production Line
Learn More
2023-03-21
Strategic Cooperation | Shanghai LKtime Biotech and Dartsbio (Guangdong) Officially Sign Strategic Cooperation Agreement
Learn More